Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 15,526–15,550 of 27,380 studies, newest first · page 622 of 1096.

January 2017 25

  1. 2017-01-01

    Down syndrome, increased risk of dementia and lipid disturbances

    ✓ Peer-reviewed Down syndrome and Alzheimer's Developmental period medicine

    Key finding: The "critical region" encompasses genes potentially associated with increase risk of dementia, e.g. the APP gene (amyloid beta precursor protein) which leads to excessive amyloid beta production. +1 more finding

  2. 2017-01-01

    Tau, Amyloid Beta and Deep Brain Stimulation: Aiming to Restore Cognitive Deficit in Alzheimer's Disease

    ✓ Peer-reviewed Down syndrome and Alzheimer's Current Alzheimer research

    Key finding: The humble success of current therapeutic strategies along with the lack of basic knowledge of the brain disease mechanisms calls for alternatives that benefit patients in the present moment. +1 more finding

  3. 2017-01-01
  4. 2017-01-01

    Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer's Disease and Late-Life Cognitive Disorders: A Systematic Review

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: In particular, higher adherence to a Mediterranean-type diet was associated with decreased cognitive decline. +1 more finding

  5. 2017-01-01

    The Gut Microbiota and Alzheimer's Disease

    ✓ Peer-reviewed Risk factors Journal of Alzheimer's disease : JAD

    Key finding: AD, the most common form of dementia, is a neurodegenerative disorder associated with impaired cognition and cerebral accumulation of amyloid-β peptides (Aβ). +3 more findings

  6. 2017-01-01

    Age and Graphomotor Decision Making Assessed with the Digital Clock Drawing Test: The Framingham Heart Study

    ✓ Peer-reviewed Digital health tools Journal of Alzheimer's disease : JAD

    Key finding: Longer age-related decision making latencies may reflect a greater need for working memory and increased self-monitoring in older subjects.

  7. 2017-01-01

    Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment

    ✓ Peer-reviewed Digital health tools Journal of Alzheimer's disease : JAD

    Key finding: The method presented in this paper can be used to separate stable MCI patients from those who are at early stages of AD dementia with high accuracy. +1 more finding

  8. 2017-01-01

    A Comparison of the Prevalence of Dementia in the United States in 2000 and 2012

    ✓ Peer-reviewed How common it is JAMA internal medicine

    Key finding: The study cohorts had an average age of 75.0 years (95% CI, 74.8-75.2 years) in 2000 and 74.8 years (95% CI, 74.5-75.1 years) in 2012 (P = .24); 58.4% (95% CI, 57.3%-59.4%) of the 2000 cohort was female compared with 56.3% (95% CI, 55.5%-57.0%) of the 2012 cohort (P Conclusions and relevance The prevalence of dementia in the United States declined significantly between 2000 and 2012. +3 more findings

  9. 2017-01-01

    Dementia Prevalence in a Rural Region of South Africa: A Cross-Sectional Community Study

    ✓ Peer-reviewed Disparities Journal of Alzheimer's disease : JAD

    Key finding: Dementia prevalence estimates were higher than expected for this low-income rural community. +2 more findings

  10. 2017-01-01
  11. 2017-01-01

    Alzheimer's Disease in the Latino Community: Intersection of Genetics and Social Determinants of Health

    ✓ Peer-reviewed Disparities Journal of Alzheimer's disease : JAD

    Key finding: Therefore, AD has reached epidemic proportions with significant socioeconomic implications. +4 more findings

  12. 2017-01-01

    The Utilization of Robotic Pets in Dementia Care

    ✓ Peer-reviewed Caregiving Journal of Alzheimer's disease : JAD

    Key finding: Treatment with the PARO robot decreased stress and anxiety in the treatment group and resulted in reductions in the use of psychoactive medications and pain medications in elderly clients with dementia. +1 more finding

  13. 2017-01-01

    Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data

    ✓ Peer-reviewed Caregiving Age and ageing

    Key finding: Such complex needs require an integrated response from general health professionals and multidisciplinary dementia specialists.

  14. 2017-01-01

    Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

    ✓ Peer-reviewed Caregiving The Lancet. Neurology

    Key finding: These samples were graded on an ordinal scale and genotyped for variants associated with synucleinopathies. +1 more finding

  15. 2017-01-01
  16. 2017-01-01

    Prevalence of Depression in Patients With Mild Cognitive Impairment: A Systematic Review and Meta-analysis

    ✓ Peer-reviewed Getting a diagnosis JAMA psychiatry

    Key finding: Of 5687 unique abstracts, 255 were selected for full-text review, and 57 studies, representing 20 892 patients, met all inclusion criteria. +4 more findings

  17. 2017-01-01

    Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index

    ✓ Peer-reviewed Prevention and risk Journal of Alzheimer's disease : JAD

    Key finding: LIBRA might be a useful tool to identify individuals for primary prevention interventions of dementia in midlife, and maybe in late life, but not in the oldest-old. +1 more finding

  18. 2017-01-01

    Alzheimer's Disease and Exercise: A Literature Review

    ✓ Peer-reviewed Prevention and risk Current sports medicine reports

    Key finding: It is the leading cause of dementia in late adult life and is associated with a significant social burden and increased morbidity and mortality in the elderly. +2 more findings

  19. 2017-01-01

    Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease

    ✓ Peer-reviewed Prevention and risk JAMA neurology

    Key finding: These findings suggest amyloid pathologies significantly influence white matter and that these abnormalities may signify an early feature of the disease process. +3 more findings

  20. 2017-01-01

    Update on Alzheimer's Disease Therapy and Prevention Strategies

    ✓ Peer-reviewed Prevention and risk Annual review of medicine

    Key finding: Significant investments in therapeutic drug discovery programs over the past two decades have yielded some important insights but no blockbuster drugs to alter the course of disease. +2 more findings

  21. 2017-01-01

    Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid

    ✓ Peer-reviewed Treatments Journal of Alzheimer's disease : JAD

    Key finding: Our results suggest that risperidone may affect the CSF profile of AD biomarkers indicating more amyloid pathology. +4 more findings

  22. 2017-01-01

    Alzheimer's Disease and Chinese Medicine as a Useful Alternative Intervention Tool: A Mini-Review

    ✓ Peer-reviewed Treatments Current Alzheimer research

    Key finding: The authors of this mini-review list the key benefits (e.g., positive results of the reviewed randomized clinical trials studies for the improvement of cognitive decline in AD) and limitations (e.g., low awareness of benefits of TCM in Europe) of Chinese medicine therapy for the treatment of AD. +1 more finding

  23. 2017-01-01

    Do Hearing Aids Influence Behavioral and Psychological Symptoms of Dementia and Quality of Life in Hearing Impaired Alzheimer's Disease Patients and Their Caregivers?

    ✓ Peer-reviewed Treatments Journal of Alzheimer's disease : JAD

    Key finding: These findings do not provide evidence of improvement in behavioral symptoms, functional status, or QoL of hearing impaired AD patients and their caregivers after 6 months of HA use. +3 more findings

  24. 2017-01-01

    Cognitive Changes with Omega-3 Polyunsaturated Fatty Acids in Non-Demented Older Adults with Low Omega-3 Index

    ✓ Peer-reviewed Treatments The journal of nutrition, health & aging

    Key finding: We found some evidence that n-3 PUFAs might be beneficial for the maintenance of executive functioning in older adults at risk of dementia with low omega-3 index, but this exploratory finding requires further confirmation. +2 more findings

  25. 2017-01-01

    Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype

    ✓ Peer-reviewed Genetics JAMA neurology

    Key finding: Among the 183 study participants, mean (SD) age was 85.5 (3) years, 76 were women (41.5%), and 177 were white (96.7%). +3 more findings

Browse the library by subject, with the full score breakdown →